Solvotrin Therapeutics Latest News
Irish pharmaceutical firm works on cancer-prevention drug (Siliconrepublic.com 3rd November 2011)
Irish pharmaceutical company Solvotrin Therapeutics is developing a range of aspirin prodrugs that could be used in the fight against cancer... Read the full article
Solvotrin Therapeutics CEO Addresses “IRELAND DAY” at the
New York Stock Exchange
(14th March 2011)
Pat O’Flynn addressed a group of more than 300 executives from America’s biggest companies...Read the full article
Minister for Enterprise, Trade and Innovation, visits Solvotrin Therapeutics
office in Cork
(14th January 2011)
Minister for Enterprise, Trade and Innovation, Batt O'Keeffe made a visit to the Solvotrin Therapeutics office in Cork...Read the full article
Solvotrin Therapeutics awarded the Enterprise Ireland Life-science and
Food Commercialisation Award
(October 20th 2010)
Life-science & Food Commercialisation Award winner Pat O'Flynn, of Solvotrin Therapeutics with Conor Lenihan, Minister for Innovation and Feargal O'Morain, Enterprise Ireland...Read the full article
Merck to market: Life science firms pitch to Pharma giant
(Irish Times - 19th October 2010)
IRELAND’S INDIGENOUS life sciences industry was showcased at an event in Dublin yesterday that saw 31 entrepreneurs pitch for funding from one of the world’s leading pharmaceutical companies...Read the full article
Cork Pharma Company poised to take on the Multi Billion Dollar Aspirin market
- With the prospect of 100 new jobs for Cork
(Profile Communications - 5th June 2010)
Cork-based Solvotrin Therapeutics is poised to take on the $15 billion anti-platelet market with the development of its worldwide protected bio-activated Aspirin drug that delivers all the benefits without the side effect of gastro-intestinal bleeding...Read the full article
Enterprise Ireland To Showcase Eleven Irish-Based Pharmaceutical And Biotech
Companies During BIO International Convention
(Pharmiweb.com - 4th May 2010)
Enterprise Ireland (EI), the government agency tasked with developing and promoting the indigenous Irish business sector, will host 11 companies that exemplify the country’s preeminence in biotechnology and pharmaceutical innovation during the 2010 BIO International Convention in Chicago....Read the full article
ASPIRIN BREAKTHROUGH - Trinity scientists retain the power
of humble pill while getting rid of the side effects
(The Daily Mail - 15th March 2010)
"It's the world's most commonly prescribed medicine. But now scientists are in the process of developing a new type of aspirin which prevents the unpleasant side effects associated with the drug. Solvotrin Therapeutics, a Dublin based pharmaceutical firm, is in the initial stages of creating a form of aspirin to limit nausea and the risk of stomach ulcers for patients who take it regularly..."Read the full article (PDF)
Ten new spinouts emerge from Trinity College
(Silicon Republic - 10th March 2010)
Ten new spin-out firms have emerged out of research commercialised at Trinity College in the areas of ICT, bioscience and physical science...Read the full article